4//SEC Filing
Goodman Tony 4
Accession 0001213900-18-010085
CIK 0001513525other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:06 PM ET
Size
7.5 KB
Accession
0001213900-18-010085
Insider Transaction Report
Form 4
Goodman Tony
DirectorChief Operating Officer
Transactions
- Purchase
Common Stock
2018-07-31+7,000→ 8,755 total - Purchase
Warrant to purchase common stock
2018-07-31+7,000→ 7,000 totalExercise: $6.25From: 2018-07-31Exp: 2023-07-31→ Common Stock (7,000 underlying)
Footnotes (1)
- [F1]On July 31, 2018, the reporting person purchased 7,000 units (the "Units") in the initial public offering (the "IPO") of Adial Pharmaceuticals, Inc. (the "Company") at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant). Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO.
Documents
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001717971
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 4:06 PM ET
- Size
- 7.5 KB